Viral Load and CD4 T Cell Percentage Predict Sleep Disturbances in HIV-Infected Children
I. Okocha(Baylor College of Medicine), William T. Shearer(Baylor College of Medicine), Daniel G. Glaze(Baylor College of Medicine), Mary E. Paul(Texas Children's Hospital), Shahriar Shahzeidi(University of Miami), Heidi Schwarzwald, Samuel B. Foster(Baylor College of Medicine), C.D. Jackson(Baylor College of Medicine), Lisa Himic(University of Miami), James M. Reuben(The University of Texas MD Anderson Cancer Center), Andrew A. Colin(Seattle Children's Hospital), B. Lee(The University of Texas MD Anderson Cancer Center), F. Daniel Armstrong(Center for Cancer and Blood Disorders), Pim Brouwers(National Institutes of Health), E.N. Ward(Baylor College of Medicine), Evan N. Cohen(The University of Texas MD Anderson Cancer Center), Steven E. Lipshultz(Jacobs Institute), Lynnette Harris(Baylor College of Medicine), Mark W. Kline(Tulane University), Deshratn Asthana(University of Miami), T.L. Miller(University of Miami), Claudia A. Kozinetz(Feminist Archive North), G. B. Scott, J.E. Fehlis(Baylor College of Medicine)
Cited by 0
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
|Journal of Clinical Oncology|2004|709
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610